In a historic first, scientists have successfully treated a human patient in a clinical trial testing whether aging cells can be "reprogrammed" to act young again—marking a potential turning point in regenerative medicine.

The groundbreaking therapy represents years of research into cellular reprogramming, opening doors to treatments that could help people maintain youthful cell function and potentially address age-related diseases. While the trial is still in early stages, the success of this initial treatment signals real progress toward therapies that work with our biology rather than against it. Read the full story →

Today's takeaway: What once seemed like science fiction—reversing aging at the cellular level—is now moving into clinical reality.